Kristine M. Ball

Ms. Ball is the CEO of Soteria Biotherapeutics, Inc., a privately-held biotechnology company focused on immune-oncology. Before joining Soteria in 2020, she served as SVP of Corporate Strategy and CFO of Menlo Therapeutics, Inc., from 2017-2020 and as SVP and CFO of Relypsa, Inc., prior to the company’s acquisition by Galenica.